- Home
- ONEG vs ACHV Comparison
ONEG vs ACHV Comparison
Compare ONEG & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEG
- ACHV
- Stock Information
- Founded
- ONEG 2021
- ACHV N/A
- Country
- ONEG Hong Kong
- ACHV United States
- Employees
- ONEG N/A
- ACHV N/A
- Industry
- ONEG Homebuilding
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ONEG Consumer Discretionary
- ACHV Health Care
- Exchange
- ONEG Nasdaq
- ACHV Nasdaq
- Market Cap
- ONEG 156.2M
- ACHV 167.6M
- IPO Year
- ONEG 2024
- ACHV N/A
- Fundamental
- Price
- ONEG $5.30
- ACHV $4.47
- Analyst Decision
- ONEG
- ACHV Strong Buy
- Analyst Count
- ONEG 0
- ACHV 1
- Target Price
- ONEG N/A
- ACHV $12.00
- AVG Volume (30 Days)
- ONEG 464.2K
- ACHV 1.4M
- Earning Date
- ONEG 08-12-2025
- ACHV 11-06-2025
- Dividend Yield
- ONEG N/A
- ACHV N/A
- EPS Growth
- ONEG N/A
- ACHV N/A
- EPS
- ONEG 0.08
- ACHV N/A
- Revenue
- ONEG $53,205,000.00
- ACHV N/A
- Revenue This Year
- ONEG N/A
- ACHV N/A
- Revenue Next Year
- ONEG N/A
- ACHV N/A
- P/E Ratio
- ONEG $133.52
- ACHV N/A
- Revenue Growth
- ONEG N/A
- ACHV N/A
- 52 Week Low
- ONEG $1.48
- ACHV $1.84
- 52 Week High
- ONEG $13.50
- ACHV $5.78
- Technical
- Relative Strength Index (RSI)
- ONEG 19.35
- ACHV 49.33
- Support Level
- ONEG $9.00
- ACHV $4.26
- Resistance Level
- ONEG $10.82
- ACHV $4.90
- Average True Range (ATR)
- ONEG 1.42
- ACHV 0.35
- MACD
- ONEG -0.32
- ACHV -0.11
- Stochastic Oscillator
- ONEG 13.43
- ACHV 10.34
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.